My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format

Send to:

Choose Destination

    Nat Clin Pract Cardiovasc Med. 2008 May;5(5):248-9. Epub 2008 Mar 11.

    Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?

    Antzelevitch C.

    Masonic Medical Research Laboratory, 2150 Bleecker Street, Utica, NY 13501-1787, USA. ca@mmrl.edu

    PMID: 18332892 [PubMed]

    PMCID: 2548402

    Publication Types, Grant Support

    Publication Types:

    Grant Support:

    LinkOut - more resources

    Full Text Sources:

    Libraries:

    Supplemental Content

    Click here to read Click here to read Click here to read

    Related articles

    Cited by 1 PubMed Central article

    Patient drug information

    • Ranolazine (Ranexa®)

      Ranolazine is used alone or with other medications to treat ongoing angina (chest pain or pressure that is felt when the heart does not get enough oxygen). Ranolazine is in a class of medications called anti-anginals. Th...

    • Source: AHFS Consumer Medication Information

    All links from this record

    • Related Articles

      Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.

    • References for this PMC Article

      Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.

    • Free in PMC

      Free full text articles in PMC

    • Cited in PMC

      Full-text articles in the PubMed Central Database that cite the current articles.

    Recent activity